Insider Trading Arrangements |
3 Months Ended | 9 Months Ended |
|---|---|---|
|
Sep. 30, 2024
shares
|
Sep. 30, 2024
shares
|
|
| Trading Arrangements, by Individual | ||
| Non-Rule 10b5-1 Arrangement Adopted | false | |
| Rule 10b5-1 Arrangement Terminated | false | |
| Non-Rule 10b5-1 Arrangement Terminated | false | |
| Paul J. Clancy [Member] | ||
| Trading Arrangements, by Individual | ||
| Material Terms of Trading Arrangement | Paul J. Clancy, a member of our Board of Directors, adopted a trading plan on August 20, 2024 providing for the sale of up to an aggregate of 45,000 shares of our common stock until August 20, 2025.
|
|
| Name | Paul J. Clancy | |
| Title | member of our Board of Directors | |
| Rule 10b5-1 Arrangement Adopted | true | |
| Adoption Date | August 20, 2024 | |
| Expiration Date | August 20, 2025 | |
| Arrangement Duration | 365 days | |
| Aggregate Available | 45,000 | 45,000 |
| Steven Stein [Member] | ||
| Trading Arrangements, by Individual | ||
| Material Terms of Trading Arrangement | Steven Stein, our Executive Vice President and Chief Medical Officer, adopted a trading plan on August 29, 2024 providing for the sale of up to an aggregate of 29,745 shares of our common stock until August 29, 2025.
|
|
| Name | Steven Stein | |
| Title | Executive Vice President and Chief Medical Officer | |
| Rule 10b5-1 Arrangement Adopted | true | |
| Adoption Date | August 29, 2024 | |
| Expiration Date | August 29, 2025 | |
| Arrangement Duration | 365 days | |
| Aggregate Available | 29,745 | 29,745 |
| Vijay Iyengar [Member] | ||
| Trading Arrangements, by Individual | ||
| Material Terms of Trading Arrangement | Vijay Iyengar, our Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy, adopted a trading plan on August 29, 2024 providing for the sale of up to an aggregate of 77,316 shares of our common stock until August 29, 2025.
|
|
| Name | Vijay Iyengar | |
| Title | Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy | |
| Rule 10b5-1 Arrangement Adopted | true | |
| Adoption Date | August 29, 2024 | |
| Expiration Date | August 29, 2025 | |
| Arrangement Duration | 365 days | |
| Aggregate Available | 77,316 | 77,316 |
| Thomas Tray [Member] | ||
| Trading Arrangements, by Individual | ||
| Material Terms of Trading Arrangement | Thomas Tray, our Vice President, Chief Accounting Officer, adopted a trading plan on September 13, 2024 providing for the sale of up to an aggregate of 1,300 shares of our common stock until September 15, 2025.
|
|
| Name | Thomas Tray | |
| Title | Vice President, Chief Accounting Officer | |
| Rule 10b5-1 Arrangement Adopted | true | |
| Adoption Date | September 13, 2024 | |
| Expiration Date | September 15, 2025 | |
| Arrangement Duration | 367 days | |
| Aggregate Available | 1,300 | 1,300 |